Clinical Trials Logo

Malignant Melanoma Stage IIIc clinical trials

View clinical trials related to Malignant Melanoma Stage IIIc.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02439411 Completed - Clinical trials for Malignant Melanoma Stage IV

Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain

DEIS
Start date: March 3, 2015
Phase:
Study type: Observational

The purpose of this study is to analyze whether Dabrafenib +/- Trametinib are effective in overall survival, response rates and toxicity in both programs.